There have been numerous studies on the mechanism of EGFR-TKI resistance, including the T790M mutation, ERBB2 amplification, MET alterations, SCLC transformation, and so forth (Oxnard et al. The gene discussed is ERBB2; the disease is small cell lung carcinoma.